Supplementary Figure 10 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer

<p>Supplementary Figure 10. (A) Progression-free and (B) overall survival among all patients with stage III NSCLC according to ATM mutation status. (C) Progression-free and (D) overall survival among patients with stage III NSCLC who received concurrent chemoradiotherapy followed by durvalumab...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας: Biagio Ricciuti (14951247) (author)
Άλλοι συγγραφείς: Arielle Elkrief (15055750) (author), Joao Alessi (15561455) (author), Xinan Wang (15561458) (author), Yvonne Li (15561461) (author), Hersh Gupta (15561464) (author), Daniel M. Muldoon (15561467) (author), Arrien A. Bertram (14954848) (author), Federica Pecci (15561470) (author), Giuseppe Lamberti (15024714) (author), Alessandro Di Federico (15561473) (author), Adriana Barrichello (15561476) (author), Victor R. Vaz (15561479) (author), Malini Gandhi (15561482) (author), Elinton Lee (15561485) (author), Geoffrey I. Shapiro (14961801) (author), Hyesun Park (15561488) (author), Mizuki Nishino (15561491) (author), James Lindsay (15032271) (author), Kristen D. Felt (15561494) (author), Bijaya Sharma (15561497) (author), Andrew D. Cherniack (14959412) (author), Scott Rodig (15561500) (author), Daniel R. Gomez (15561503) (author), Narek Shaverdian (15561506) (author), Mehrdad Rakaee (15561509) (author), Chaitanya Bandlamudi (15047205) (author), Marc Ladanyi (15050661) (author), Pasi A. Janne (15561512) (author), Adam J. Schoenfeld (15022025) (author), Lynette M. Sholl (15032729) (author), Mark M. Awad (14961722) (author), Michael L. Cheng (15561515) (author)
Έκδοση: 2025
Θέματα:
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
_version_ 1849927631998287872
author Biagio Ricciuti (14951247)
author2 Arielle Elkrief (15055750)
Joao Alessi (15561455)
Xinan Wang (15561458)
Yvonne Li (15561461)
Hersh Gupta (15561464)
Daniel M. Muldoon (15561467)
Arrien A. Bertram (14954848)
Federica Pecci (15561470)
Giuseppe Lamberti (15024714)
Alessandro Di Federico (15561473)
Adriana Barrichello (15561476)
Victor R. Vaz (15561479)
Malini Gandhi (15561482)
Elinton Lee (15561485)
Geoffrey I. Shapiro (14961801)
Hyesun Park (15561488)
Mizuki Nishino (15561491)
James Lindsay (15032271)
Kristen D. Felt (15561494)
Bijaya Sharma (15561497)
Andrew D. Cherniack (14959412)
Scott Rodig (15561500)
Daniel R. Gomez (15561503)
Narek Shaverdian (15561506)
Mehrdad Rakaee (15561509)
Chaitanya Bandlamudi (15047205)
Marc Ladanyi (15050661)
Pasi A. Janne (15561512)
Adam J. Schoenfeld (15022025)
Lynette M. Sholl (15032729)
Mark M. Awad (14961722)
Michael L. Cheng (15561515)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Biagio Ricciuti (14951247)
Arielle Elkrief (15055750)
Joao Alessi (15561455)
Xinan Wang (15561458)
Yvonne Li (15561461)
Hersh Gupta (15561464)
Daniel M. Muldoon (15561467)
Arrien A. Bertram (14954848)
Federica Pecci (15561470)
Giuseppe Lamberti (15024714)
Alessandro Di Federico (15561473)
Adriana Barrichello (15561476)
Victor R. Vaz (15561479)
Malini Gandhi (15561482)
Elinton Lee (15561485)
Geoffrey I. Shapiro (14961801)
Hyesun Park (15561488)
Mizuki Nishino (15561491)
James Lindsay (15032271)
Kristen D. Felt (15561494)
Bijaya Sharma (15561497)
Andrew D. Cherniack (14959412)
Scott Rodig (15561500)
Daniel R. Gomez (15561503)
Narek Shaverdian (15561506)
Mehrdad Rakaee (15561509)
Chaitanya Bandlamudi (15047205)
Marc Ladanyi (15050661)
Pasi A. Janne (15561512)
Adam J. Schoenfeld (15022025)
Lynette M. Sholl (15032729)
Mark M. Awad (14961722)
Michael L. Cheng (15561515)
author_role author
dc.creator.none.fl_str_mv Biagio Ricciuti (14951247)
Arielle Elkrief (15055750)
Joao Alessi (15561455)
Xinan Wang (15561458)
Yvonne Li (15561461)
Hersh Gupta (15561464)
Daniel M. Muldoon (15561467)
Arrien A. Bertram (14954848)
Federica Pecci (15561470)
Giuseppe Lamberti (15024714)
Alessandro Di Federico (15561473)
Adriana Barrichello (15561476)
Victor R. Vaz (15561479)
Malini Gandhi (15561482)
Elinton Lee (15561485)
Geoffrey I. Shapiro (14961801)
Hyesun Park (15561488)
Mizuki Nishino (15561491)
James Lindsay (15032271)
Kristen D. Felt (15561494)
Bijaya Sharma (15561497)
Andrew D. Cherniack (14959412)
Scott Rodig (15561500)
Daniel R. Gomez (15561503)
Narek Shaverdian (15561506)
Mehrdad Rakaee (15561509)
Chaitanya Bandlamudi (15047205)
Marc Ladanyi (15050661)
Pasi A. Janne (15561512)
Adam J. Schoenfeld (15022025)
Lynette M. Sholl (15032729)
Mark M. Awad (14961722)
Michael L. Cheng (15561515)
dc.date.none.fl_str_mv 2025-11-25T13:29:11Z
dc.identifier.none.fl_str_mv 10.1158/1078-0432.30709351
dc.relation.none.fl_str_mv https://figshare.com/articles/figure/Supplementary_Figure_10_from_Clinicopathologic_Genomic_and_Immunophenotypic_Landscape_of_i_ATM_i_Mutations_in_Non_Small_Cell_Lung_Cancer/30709351
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Molecular and Cellular Biology
Cancer Detection and Diagnosis
Therapeutic Research and Development
Clinical Research and Trials
Biomarkers
Genetic biomarkers
DNA Damage and Repair
DNA repair
Lung Cancer
Precision Medicine
Translational Research
dc.title.none.fl_str_mv Supplementary Figure 10 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
dc.type.none.fl_str_mv Image
Figure
info:eu-repo/semantics/publishedVersion
image
description <p>Supplementary Figure 10. (A) Progression-free and (B) overall survival among all patients with stage III NSCLC according to ATM mutation status. (C) Progression-free and (D) overall survival among patients with stage III NSCLC who received concurrent chemoradiotherapy followed by durvalumab maintenance according to ATM mutation status.</p>
eu_rights_str_mv openAccess
id Manara_3f29af2ca0c21ff1b05157db70294ba0
identifier_str_mv 10.1158/1078-0432.30709351
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30709351
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Supplementary Figure 10 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung CancerBiagio Ricciuti (14951247)Arielle Elkrief (15055750)Joao Alessi (15561455)Xinan Wang (15561458)Yvonne Li (15561461)Hersh Gupta (15561464)Daniel M. Muldoon (15561467)Arrien A. Bertram (14954848)Federica Pecci (15561470)Giuseppe Lamberti (15024714)Alessandro Di Federico (15561473)Adriana Barrichello (15561476)Victor R. Vaz (15561479)Malini Gandhi (15561482)Elinton Lee (15561485)Geoffrey I. Shapiro (14961801)Hyesun Park (15561488)Mizuki Nishino (15561491)James Lindsay (15032271)Kristen D. Felt (15561494)Bijaya Sharma (15561497)Andrew D. Cherniack (14959412)Scott Rodig (15561500)Daniel R. Gomez (15561503)Narek Shaverdian (15561506)Mehrdad Rakaee (15561509)Chaitanya Bandlamudi (15047205)Marc Ladanyi (15050661)Pasi A. Janne (15561512)Adam J. Schoenfeld (15022025)Lynette M. Sholl (15032729)Mark M. Awad (14961722)Michael L. Cheng (15561515)CancerMolecular and Cellular BiologyCancer Detection and DiagnosisTherapeutic Research and DevelopmentClinical Research and TrialsBiomarkersGenetic biomarkersDNA Damage and RepairDNA repairLung CancerPrecision MedicineTranslational Research<p>Supplementary Figure 10. (A) Progression-free and (B) overall survival among all patients with stage III NSCLC according to ATM mutation status. (C) Progression-free and (D) overall survival among patients with stage III NSCLC who received concurrent chemoradiotherapy followed by durvalumab maintenance according to ATM mutation status.</p>2025-11-25T13:29:11ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30709351https://figshare.com/articles/figure/Supplementary_Figure_10_from_Clinicopathologic_Genomic_and_Immunophenotypic_Landscape_of_i_ATM_i_Mutations_in_Non_Small_Cell_Lung_Cancer/30709351CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307093512025-11-25T13:29:11Z
spellingShingle Supplementary Figure 10 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Biagio Ricciuti (14951247)
Cancer
Molecular and Cellular Biology
Cancer Detection and Diagnosis
Therapeutic Research and Development
Clinical Research and Trials
Biomarkers
Genetic biomarkers
DNA Damage and Repair
DNA repair
Lung Cancer
Precision Medicine
Translational Research
status_str publishedVersion
title Supplementary Figure 10 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
title_full Supplementary Figure 10 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
title_fullStr Supplementary Figure 10 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
title_full_unstemmed Supplementary Figure 10 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
title_short Supplementary Figure 10 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
title_sort Supplementary Figure 10 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
topic Cancer
Molecular and Cellular Biology
Cancer Detection and Diagnosis
Therapeutic Research and Development
Clinical Research and Trials
Biomarkers
Genetic biomarkers
DNA Damage and Repair
DNA repair
Lung Cancer
Precision Medicine
Translational Research